Ivera Medical Corporation

Ivera Medical Corporation
Share
Curos® Port Protectors provide consistent and reliable disinfection and protection of all currently available luer- activated valves. Their vibrant green color provides a tool for facilities to confirm and improve clinician compliance of valve disinfection procedures. Stop by the Ivera Medical booth and learn how Curos can assist your facility in the reduction of bloodstream infections. GREEN is CLEAN...Use CUROS

Ivera Medical Corporation

 •  March 21, 2016

Background:
Central line-associated bloodstream infections (CLABSIs) result in increased length of stay, cost, and patient morbidity and mortality. One CLABSI prevention method is disinfection of intravenous access points. The literature suggests that placing disinfectant caps over needleless connectors decreases CLABSI risk.
Methods:
A...

Ivera Medical Corporation

 •  September 16, 2015

Background: Central line-associated blood stream infections (CLABSIs) affect thousands of patients each year and cost healthcare billions of dollars. Vascular catheter associated infections are the focus of regulatory, accrediting, and prospective payment agencies. The objective of the project was to achieve and sustain a rate of zero CLABSIs by ...

Ivera Medical Corporation

 •  September 16, 2015

Presented at APIC 2015
Ramona Karam-Howlin, Andrea Fede, Kathleen Gibbs, Nathaniel Bravo, Fran Wallach and Gopi Patel.
Mount Sinai Hospital, New York City, NY Background: The NICU was noted to have a high overall central line associated blood stream infection (CLABSI) rate of 5.2 per 1000 line days in 2012. Our objective was to incorporate best ...

Ivera Medical Corporation

 •  September 16, 2015

Gurminder Kaur
Texas Health Presbyterian Hospital Dallas Background: Adult ICUs were experiencing an increase in CLABSIs since the beginning of the 2013 despite adherence to various evidence-based strategies. The goal was to have no CLABSIs in November & December, 2013, and to sustain this improvement. Methods: An interdisciplinary team of ICU ...

Ivera Medical Corporation

 •  March 14, 2015

3M announced today that it has completed its acquisition of Ivera Medical Corp., a manufacturer of health care products that disinfect and protect devices used for access into a patient’s bloodstream. The business is now a wholly owned subsidiary of 3M and a part of its Critical & Chronic Care Solutions Division. 3M’s vascular access products play ...

Ivera Medical Corporation

 •  February 20, 2015

Acquisition Expands 3M’s Vascular Access Offerings PAUL, Minn., Feb 19, 2015(BUSINESS WIRE) — 3M announced today that it has entered into a definitive agreement to acquire Ivera Medical Corp., a manufacturer of health care products that disinfect and protect devices used for access into a patient’s bloodstream. Terms of the transaction were not ...

Ivera Medical Corporation

 •  February 12, 2015

Ivera Medical announced today that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for a new patent for its innovative Curos® disinfecting port protector technology. Issued on February 3, 2015, this new patent will be directed to Ivera’s core technology for its Curos Port Protector and Curos Strip products. “We ...

Ivera Medical Corporation

 •  January 27, 2015

Ivera Medical Corporation has met the stringent requirements for a minority-owned business enterprise (MBE) for the fourth consecutive year. The Pacific Southwest Minority Supplier Development Council has renewed the certification for MBE status, as defined by the National Minority Supplier Development Council certification guidelines. “Our MBE ...

Ivera Medical Corporation

 •  November 12, 2014

Presented at SHEA ID Week 2014 Mark Shelly, Linda Greene, Lynne Brown, Sherry Romig, Ann Marie Pettis. Highland Hospital and University of Rochester Medicine, Rochester, NY Abstract Background: Improvements in central line placement practices have decreased the rates of central line associated bloodstream infections (CLABSI). Further progress in ...

Ivera Medical Corporation

 •  November 5, 2014

Ivera Medical announced that an independent lab has found that the dark blue IV-Pole Strips and DualCap products for male luer connectors made by Catheter Connections failed in a second test to disinfect all critical surfaces of male luer connectors when used as directed on Candida albicans. Previously, results were published from an independent ...